Le Lézard
Classified in: Mining industry, Science and technology, Covid-19 virus
Subject: SHM

CYMAT PROVIDES UPDATE ON STATUS OF JANUARY 13, 2022 SHAREHOLDER MEETING


/NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./

MISSISSAUGA, ON, Jan. 6, 2022 /CNW/ - Cymat Technologies Ltd. (TSXV: CYM) (the "Company" or "Cymat") is providing the following update on the status of the AGM to be held on January 13, 2022 at 10:30 a.m. EST.

Cymat originally planned to hold an in-person shareholder meeting (the "Meeting") at their Mississauga office and manufacturing facility as indicated in the Notice of Annual Meeting of Shareholders issued on December 7, 2021. However, due to a significant increase in the Covid-19 case counts, the Government of Ontario has enacted restrictions which include a limit on indoor public gatherings to a maximum of five (5) persons. As a result of these restrictions and Cymat's concern for the health and safety of its employees, shareholders and the community at large, the Meeting will no longer be in-person.

The formal portion of the Meeting which includes voting on matters as described in the Management  Information Circular dated December 7, 2021, will still take place as scheduled. However, shareholders will not be permitted to physically attend the meeting. Management strongly encourages shareholders to submit their votes in advance of the meeting and prior to the cutoff time of 10:30 a.m. (EST) on January 11, 2022, either by voting online at www.voteproxyonline.com or by voting facsimile at (416) 595-9593.

Historically, the formal portion of the Meeting has been followed by a management presentation providing an update on Cymat's operational and business development activities. That informal portion of the meeting will be postponed to a future date when such an in-person gathering can be safely held.

 About Cymat Technologies Ltd.

Cymat Technologies Ltd. has the global rights, through patents and established know-how, to manufacture and sell Stabilized Aluminum Foam ("SAF"), a unique, ultra-light, cellular metallic material. The proprietary production process entails the injection of gases through a molten bath of alloyed aluminum infused with ceramic particles. The result is an advanced, lightweight, recyclable material that exhibits unique characteristics including: customizable density and dimensions; mechanical energy absorption; thermal and acoustic insulation; and time, temperature and strain-rate insensitivity. A key benefit of this continuous foam production process is its scalability and resultant low cost of production. SAF is used in such industries as architectural design, military and automotive. Cymat markets its architectural SAF under the AlusionTM brand and its automotive and military SAF under the SmartMetalTM brand. For further information , please visit our website at www.cymat.com.

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions and dependence upon regulatory approvals. Certain material assumptions regarding such forward-looking statements may be discussed in this news release and the Company's annual and quarterly management's discussion and analysis filed at www.sedar.com. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

No securities regulatory authority has either approved or disapproved of the contents of this news release. The Shares have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States, or to or for the account or benefit of any person in the United States, absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any common shares in the United States, or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. We seek safe harbour.

Neither the Toronto Venture Exchange (TSXV) nor its Market Regulator (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Cymat Technologies Ltd.


These press releases may also interest you

at 08:31
Vicinity Motor Corp. ("Vicinity" or the "Company"), a North American supplier of commercial electric vehicles, today announced that it will showcase the VMC 1200 Class 3 Electric Truck at the Advanced Clean Transportation Expo...

at 08:30
The "Global Military Aviation MRO Market (2024 Edition): Analysis By Aircraft Type (Fixed Wing Aircraft and Rotorcraft), By MRO Service Type, By Category, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to...

at 08:30
Global biotechnology leader CSL (ASX:CSL;...

at 08:20
The "Global Orthopedic Soft Tissue Repair Market (2024 Edition): Analysis By Injury Location (Knee, Shoulder, Hip, Small Joints), By Application, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to...

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that the Alzheimer's Drug Discovery Foundation ("ADDF") has purchased...

at 08:10
The "Global Retail Media Market (2024 Edition): Analysis By Platform (In-store, Online), By Advertising Format, By Application, By Region, By Country: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's...



News published on and distributed by: